Please login to the form below

Chile

This page shows the latest Chile news and features for those working in and with pharma, biotech and healthcare.

Israel, Sweden and Chile have made fourth vaccination doses available to older adults and other clinically vulnerable or high-risk groups.

UCB boosts gene therapy offering with a pair of new deals

This includes platforms licensed from KU Leuven in Belgium, the Centre for Applied Medical Research in Spain, the University of Chile and King’s College London in the UK.
Regeneron launches phase 3 COVID-19 antibody trial in the UK

Meanwhile, the two phase 2/3 treatment trials are planned to be conducted at approximately 150 sites in the US, Brazil, Mexico and Chile, and will evaluate virologic and clinical endpoints.
China’s CanSino Biologics reveals phase 2 coronavirus vaccine results

According to Reuters, CanSino is in discussions with a number of countries, including Russia, Brazil, Chile and Saudi Arabia, to launch a large-scale phase 3 trial testing its vaccine candidate,
Regeneron’s COVID-19 antibody cocktail enters phase 3 trial

Meanwhile, the two phase 2/3 treatment trials are planned to be conducted at approximately 150 sites in the US, Brazil, Mexico and Chile, and will evaluate virologic and clinical endpoints.
Policy and public health COVID-19 by the numbers

This number exceeds the total number of active ventilators in Mexico, Colombia, Argentina and Chile combined by 13, 000.

More from news
Approximately 0 fully matching, plus 19 partially matching documents found.

Safe from harm?

Which healthcare systems inspire patient confidence? According to a new global study into healthcare perceptions, only 1 in 4 Britons (26%) are very confident in their national health service, with Chile ... Across the world, attitudes towards healthcare
Focusing on value

The food supplement for gastro-intestinal problems was launched in January in Chile, as part of its Latin American roll-out.
Deal Watch table for May 2014

Company acquisition. Chile-based branded generic company with Latin America (2013 sales $768m).
Pharma deals during May 2014

The traditional Big Pharma business model was continued in the month with Abbott acquiring the Chile-based branded generic company, CFR Pharmaceuticals for $3.3bn (4.3 x sales, 34 x
Pharma deals during September 2013

Foreign intervention. Staying in South Africa; CFR Pharmaceuticals, Chile's largest pharmaceutical company, has announced the final terms for the acquisition of South Africa's A dcock Ingram for $1.3bn.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

MHP Communications adds two directors to health unit

director for Pfizer Chile.
Oscar Ferenczi joins Grünenthal from Sandoz

Prior to this period, he spent more than at decade at Merck &Co in the region, including spells as general manager Ecuador, general manager Peru, general manager Chile, and VP and

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Interactive infographic: LATAM

The LATAM region's largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth region.
Infographic: LATAM

Latin America. The LATAM regions largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth region.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

Exciting Medical Writer Career Opportunity for Postdoc, Medcomms: Highly competitive salary

Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...: Highly competitive salary

Add my company

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

The challenges of identifying rare diseases: With increased awareness and improved diagnosis, more rare diseases are being recognised and this number is likely to increase in the coming years...
5 ways we’re enhancing our services to support our clients in 2023: Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023....
ASH 2022: bad blood but big advances: Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...

Email:
Password: